Kamada Ltd risk profile

32 Normal where most of the sector sits

Measured 21 October 2026 from KMDA's filed statements. Recomputed nightly.

32 (Normal), driven by Competitive position at 44, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation43ElevatedStableOne-year price volatility — 35.4%
Operating pressure24NormalWorseningCosts outgrowing revenue — -2.7 percentage points
Cash conversion37NormalWorseningCapital spending against operating cash — 0.39x
Leverage and coverage2ContainedStableCurrent ratio — 4.07x
Competitive position44ElevatedWorseningR&D-intensity gap against peers — -19.9 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Kamada Ltd